Non-Alcoholic Fatty Liver Disease (NAFLD): The Emerging Pandemic | Product


Non-alcoholic fatty liver disease has silently become a worldwide pandemic. It is typically asymptomatic at first, but can slowly progress into a much more serious condition called steatohepatitis (NASH) that leads to irreversible scarring, cirrhosis, and liver failure. NAFLD is strongly associated with a wide range of co-morbidities, including obesity, metabolic syndrome, and type 2 diabetes. Other than using pharmaceuticals to control blood sugar and elevated lipids, mainstream medicine does not provide any effective treatments that can reverse the condition. This presentation will review the mechanisms behind dietary, environmental, and lifestyle factors implicated in the development of NAFLD and its progression to NASH. We will then examine the published evidence supporting a range of nutritional and botanical solutions that have the potential to halt and possibly reverse the condition. This presentation was recorded at the Integrative Healthcare Symposium Annual Conference.